Archives: Staff

Aparaajita Balaji, PhD

Dr. Aparaajita Balaji joined Longwood Fund’s investment team in 2026. She brings expertise spanning venture investing, company formation, and scientific research across a broad range of therapeutic areas and modalities. Prior to Longwood, Aparaajita was an investor at KB Investment, where she led diligence on investments from early discovery-stage companies through late-stage programs approaching NDA […]

Sean O’Connor, PhD

Sean O’Connor joined Longwood Fund in 2026 as a Principal on the investment team. He was previously a Principal at the T1D Fund, where his investments included SAB Bio (NASDAQ: SABS), vTv Therapeutics (NASDAQ: VTVT), Zag Bio, Mozart Therapeutics, and others.  Prior to the T1D Fund, Sean was a Project Leader at the Boston Consulting Group, […]

Roger Tung, PhD

Roger Tung, Ph.D., is an entrepreneur with deep expertise in small-molecule drug R&D. He earned his doctorate in pharmaceutical chemistry from the University of Wisconsin-Madison before beginning his career at Merck & Co. He then joined Vertex Pharmaceuticals as a founding scientist, where he played a pivotal early role in initiating and leading research efforts. […]

Vikas Goyal, MBA

Vikas Goyal has been working in the biotech industry for 20 years, with a particular focus on corporate strategy, capital formation, corporate partnerships, and M&A for early stage therapeutics companies. Vikas is a Partner at Longwood Fund where he focuses on growth stage investments in late preclinical and clinical stage biotechnology companies. Prior to joining […]

Josh Lubov, MBA, CPA

Josh Lubov is the Chief Financial Officer of Longwood Fund, where he oversees the firm’s financial and operational functions. In this role, he manages fund finance and reporting, supports investment activities, contributes to fund planning and strategy, and oversees limited partner communications, portfolio support, and liquidity management. Josh brings more than 25 years of experience […]

John McCabe, MBA

John McCabe is Portfolio Company Chief Financial and Chief Operating Officer at Longwood Fund and has served as the CFO/COO of Longwood-founded companies Newleos Therapeutics, Inc., Solu Therapeutics, Inc., Weaver Biosciences, Inc. and DEM Biosciences, Inc. Prior to Longwood Fund, John served as CFO of Oncorus, Inc. Before joining Oncorus, John served in various roles […]

Rob Hadfield, JD

Rob Hadfield is General Counsel and Operating Partner of Longwood Fund where he oversees all legal matters of the Fund and assists with due diligence, new company formations and operations, and portfolio company management. Rob has extensive executive experience, having served as the general counsel for two public life science companies, with oversight responsibilities of […]